SA PRO
Free Account
Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
LOADING
|||
OverviewNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
18 analysts·Moderate coverage
100%
Rating Distribution
Strong Buy
00%
Buy
18100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 40% higher.

Bear Case
$123.00
+21%
Consensus
$142.17
+40%
Bull Case
$157.00
+54%
Price Range18 analysts
Low
Consensus
High
$123.00
$157.00
Current Target
Current Price
$101.63
Upside to Target
$40.54

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 22, 2025H.C. Wainwright
Rhythm Pharmaceuticals price target raised to $123 from $110 at H.C. Wainwright
Target:$123.00
+9.7%from $112.14
Dec 17, 2025Guggenheim
Rhythm Pharmaceuticals price target raised to $140 from $120 at Guggenheim
Target:$140.00
+24.5%from $112.45
Dec 12, 2025Goldman Sachs
Rhythm Pharmaceuticals price target raised to $157 from $141 at Goldman Sachs
Target:$157.00
+33.6%from $117.52
Dec 12, 2025Canaccord Genuity
Rhythm Pharmaceuticals price target raised to $141 from $114 at Canaccord
Target:$141.00
+20.0%from $117.52
Dec 11, 2025Morgan Stanley
Rhythm Pharmaceuticals price target raised to $150 from $129 at Morgan Stanley
Target:$150.00
+27.6%from $117.52
Oct 17, 2025Goldman Sachs
Rhythm Pharmaceuticals price target lowered to $139 from $157 at Goldman Sachs
Target:$139.00
+25.0%from $111.18
Oct 16, 2025Morgan Stanley
Rhythm Pharmaceuticals price target raised to $129 from $122 at Morgan Stanley
Target:$129.00
+18.0%from $109.35
Sep 29, 2025H.C. Wainwright
Rhythm Pharmaceuticals price target raised to $110 from $100 at H.C. Wainwright
Target:$110.00
+10.9%from $99.16
Sep 25, 2025JMP Securities
Rhythm Pharmaceuticals price target raised to $142 from $135 at Citizens JMP
Target:$142.00
+43.8%from $98.76
Aug 5, 2025Morgan Stanley
Rhythm Pharmaceuticals price target raised to $109 from $100 at Morgan Stanley
Target:$109.00
+23.1%from $88.57
Jul 10, 2025Oppenheimer
Rhythm Pharmaceuticals price target raised to $110 from $76 at Oppenheimer
Target:$110.00
+23.5%from $89.04
Jul 10, 2025Goldman Sachs
Rhythm Pharmaceuticals resumed with a Buy at Goldman Sachs
Target:$97.00
+8.9%from $89.04
Jul 9, 2025Morgan Stanley
Rhythm Pharmaceuticals price target raised to $95 from $80 at Morgan Stanley
Target:$95.00
+6.7%from $89.00
Mar 5, 2025Stifel Nicolaus
Rhythm Pharmaceuticals resumed with a Buy at Stifel
Target:$78.00
+47.3%from $52.97
Mar 3, 2025H.C. Wainwright
Rhythm Pharmaceuticals price target raised to $70 from $69 at H.C. Wainwright
Target:$70.00
+33.6%from $52.40
Jan 1, 2025Jefferies
Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential
Target:$80.00
+42.9%from $55.98
Dec 5, 2024Goldman Sachs
Rhythm Pharmaceuticals (RYTM) PT Raised to $66 at Goldman Sachs
Target:$66.00
+10.0%from $60.02
Nov 6, 2024Needham
Rhythm Pharmaceuticals (RYTM) PT Raised to $64 at Needham
Target:$64.00
+14.7%from $55.78
Nov 6, 2024Goldman Sachs
Rhythm Pharmaceuticals (RYTM) PT Raised to $59 at Goldman Sachs
Target:$59.00
+5.8%from $55.78
Sep 18, 2024H.C. Wainwright
Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright
Target:$64.00
+20.4%from $53.17
Sep 17, 2024JMP Securities
JMP Securities Starts Rhythm Pharmaceuticals (RYTM) at Market Outperform
Target:$64.00
+18.5%from $54.00
Jul 25, 2024Needham
Rhythm Pharmaceuticals (RYTM) PT Raised to $55 at Needham
Target:$55.00
+10.9%from $49.61
Nov 10, 2022Goldman Sachs
Goldman Sachs Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $35
Target:$35.00
+41.8%from $24.68
Aug 7, 2022Goldman Sachs
Rhythm Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
Target:$28.00
+38.3%from $20.24
Jul 12, 2022Goldman Sachs
Rhythm Pharmaceuticals price target raised to $6 from $4 at Goldman Sachs
Target:$6.00
-6.0%from $6.38

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance